Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Skin issues in PCOS signal hormone problems, and combined treatments improve outcomes.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Finasteride effectively reduces hair loss by decreasing androgen levels.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Testosterone therapy improved physical and social health in a male with 49,XXXXY syndrome.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

Skin health and diseases are closely linked to metabolic processes.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Relatives of women with PCOS symptoms are more likely to have similar health issues.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.